SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE)

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COMMON STOCK
Total 13F shares
12,885,767
Share change
-218,182
Total reported value
$69,317,000
Put/Call ratio
550%
Price per share
$5.38
Number of holders
68
Value change
-$3,468,733
Number of buys
35
Number of sells
34

Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q1 2016

As of 31 Mar 2016 SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) had 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 12,885,767 shares of stock of the company.
Largest 10 holders included Wildcat Capital Management, LLC, Cormorant Asset Management, LLC, venBio Select Advisor LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, SABBY MANAGEMENT, LLC, FRANKLIN RESOURCES INC, and NORTHERN TRUST CORP.
This table shows 68 institutional shareholders of the security as of 31 Mar 2016.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.